Skip to main content
Premium Trial:

Request an Annual Quote

Horizon HDx FFPE RNA Fusion Reference Standards

Horizon Discovery Group has launched its HDx FFPE RNA Fusion reference standards. These standards are highly-characterized, biologically relevant, and quality independent analytical controls for the optimization and validation of targeted RNA-seq, endpoint RT-PCR, or RT-qPCR assays, the company said. Each section contains a formalin-fixed, paraffin-embedded cell line multiplex verified to contain EML4-ALK (Variant 1), CCDC6-RET, and SLC34A2-ROS1 fusions  all important clinical markers for non-small cell lung cancer.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.